ストックスクリーナーアプリを入手
122.09
2.39%
-2.99
アフターアワーズ：
122.09
Abbott Laboratories (ABT) 最新ニュース
Abbott (ABT) Expands Lingo Glucose Monitor to Android Users - GuruFocus
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump - AOL.com
Abbott (NYSE: ABT) adds Lingo to Android, cites 15% lower odds of glucose spikes - Stock Titan
SVB Wealth LLC Has $12.17 Million Stake in Abbott Laboratories $ABT - MarketBeat
Divergent Views Emerge on Abbott Laboratories’ Stock Valuation - AD HOC NEWS
The Minnesotan behind Cologuard, which fueled the biggest health care acquisition of 2025 - Star Tribune
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives - Finviz
Abbott (ABT) awards $1 million as Big Ten drive logs 83,043 blood donations - Stock Titan
Seaview Investment Managers LLC Purchases New Stake in Abbott Laboratories $ABT - MarketBeat
UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition - MSN
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Is Abbott Laboratories Fairly Priced After Growth In Devices And Diagnostics? - Yahoo Finance
FDA Warning For Abbott Glucose Sensors After 700 Injuries, 7 DeathsAbbott Laboratories (NYSE:ABT) - Benzinga
Healthtech Market Is Booming Worldwide With Boston Scientific, Philips Healthcare, Abbott Laboratories, - EIN News
Guggenheim Capital LLC Buys 11,794 Shares of Abbott Laboratories $ABT - MarketBeat
Assessing Abbott After 10.5% Gains and DCF PE Signals Amid Exact Sciences Deal Talk - simplywall.st
The Zacks Analyst Blog Highlights HSBC, Abbott, Shell and Oak Valley - Yahoo Finance
Arrowstreet Capital Limited Partnership Purchases 291,987 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (NYSE:ABT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Diabetes Glucose Monitors Recalled After 7 Deaths and More Than 700 Injuries - People.com
Top Analyst Reports for HSBC, Abbott & Shell - Yahoo Finance
Medtronic launches new diabetes tech integrated with Abbott sensor - Cardiovascular Business
FDA Issues Warning on Abbott (ABT) Glucose Monitors After Reported Deaths - GuruFocus
How Abbott Laboratories (ABL) stock trades after rate cuts2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
Faulty Glucose Monitor Sensors May Be Tied to 7 Deaths, F.D.A. Says - The New York Times
Abbott Launches Two New Ensure Max Protein Shakes to Tap into Growing Muscle Health Movement - marketscreener.com
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and MoreResearchAndMarkets.com - The AI Journal
Muscles, the New Flex: Abbott Launches Two New Ensure Max Protein Shakes to Tap into Growing Muscle Health Movement - Finviz
Abbott (NYSE: ABT) debuts Ensure Max Protein 42g, 2 in 1 shakes with Walmart rollout - Stock Titan
Millions of Abbott Glucose Sensors Recalled After Faulty Readings Linked to Deaths - The Suburban
Abbott - The Pharma Letter
Don't Ignore The Insider Selling In Abbott Laboratories - simplywall.st
Abbott Laboratories $ABT Stake Lifted by First Trust Advisors LP - MarketBeat
Baird Financial Group Inc. Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Medtronic launches insulin delivery system with Abbott-made sensor - MedTech Dive
Abbott Laboratories' (NYSE:ABT) Price Is Right But Growth Is Lacking - 富途牛牛
Seven States Join Abbott Infant Formula FCA Lawsuit, Alleging Years of Violations and Cover-Ups - USA Herald
Abbott Defends Glucose Monitor Patents In Sinocare Fight - Law360
Abbott Laboratories (NYSE: ABT) sees Vanguard report 10.05% beneficial stake - Stock Titan
The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock - sharewise.com
7 deaths, hundreds of injuries may be linked to diabetes glucose monitor errors, FDA says - CBS News
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
M&T Bank Corp Trims Stake in Abbott Laboratories $ABT - MarketBeat
Shelton Capital Management Has $8.97 Million Stake in Abbott Laboratories $ABT - MarketBeat
Loomis Sayles & Co. L P Raises Position in Abbott Laboratories $ABT - MarketBeat
Can Abbott Laboratories stock weather global recessionForecast Cut & AI Based Buy and Sell Signals - Newser
Invesco Ltd. Increases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
States Hit Abbott With FCA Suit Over Infant Formula Recall - Law360
7 deaths linked to faulty blood glucose monitors as FDA issues safety warning - Fox Business
Seven deaths linked to malfunctioning glucose monitors - USA Today
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott - Medtronic
Smith Moore & CO. Has $3.40 Million Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories CEO Robert Ford sells $37.4 million in stock - MSN
Here's Why We Think Abbott Laboratories (NYSE:ABT) Is Well Worth Watching - Yahoo Finance
Abbott Laboratories (ABT) Stock Analysis Report | Financials & Insights - Benzinga
This Top Dividend King Just Became an Even Better Buy - AOL.com
Fisher Asset Management LLC Raises Holdings in Abbott Laboratories $ABT - MarketBeat
Immunoassay Market to Get an Explosive Growth | BD, Abbott, Sysmex Corporation - openPR.com
Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now - ts2.tech
Abbott Moves to Acquire Exact Sciences - Dark Daily
Abbott acquires Madison-based Exact Sciences in health care deal - The Daily Cardinal
Exact Sciences sale could benefit both companies, local economist says - The Cap Times
Abbott Laboratories $ABT Stake Increased by Schroder Investment Management Group - MarketBeat
Stifel downgrades Exact Sciences stock rating to Hold following Abbott acquisition news - Investing.com India
West Family Investments Inc. Has $1.29 Million Stake in Abbott Laboratories $ABT - MarketBeat
3.77%
大文字化:
|
ボリューム (24 時間):